Upfront Abiraterone for mCRPC Tied to Better Survival in Black vs White Men
In a study of men receiving first-line abiraterone for metastatic castration-resistant prostate cancer, Black men had a lower risk for death compared with White men.
Genitourinary Cancer
Corticosteroids May Reduce Benefit From Enzalutamide in Prostate Cancer
Patients taking corticosteroids at baseline had significantly worse outcomes.
Black Prostate Cancer Patients Fare Better With RT, Despite More Aggressive Disease
Black race was associated with lower rates of biochemical relapse, distant metastases, and prostate cancer-specific mortality.
Metformin Use Linked to Prostate Cancer Risk
In a large study of men with newly diagnosed diabetes, exposure to metformin in the previous year was associated with an increased risk for a prostate cancer diagnosis, whereas exposure 2 to 7 years previously was associated with decreased risk.
Prostate Cancer Death Risk Not Higher Among Black Men
New findings are consistent with recent pooled analyses in which adjustment for nonbiological differences, including socioeconomic status and health care access, eliminate the increased risk of death from prostate cancer observed in Black men.
Oncologic Outcomes After RP for High-Risk Prostate Cancer Characterized
Metastasis-free and overall survival are modest among men who have lymph node involvement and persistent detectable PSA after radical prostatectomy for high-risk prostate cancer, a study found.
3D Imaging Technique Aids Diagnosis of Aggressive Prostate Cancer
A 3D method improved the assessment of glandular features over traditional pathology.
PSMA Nomogram May Predict Outcomes in Prostate Cancer
Compared with other risk-stratification tools, the nomogram performed favorably.
Long-Term Prostate Cancer Mortality Patterns Defined
Most prostate cancer deaths occur among men initially diagnosed with low-grade disease, according to investigators.
Statin Use Does Not Change Benefits of Prostate Cancer Screening
Regardless of statin use, screening was associated with a lower incidence of metastatic tumors.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...